SCHEMBL23253142

SCHEMBL23253142

Cc1ccc(-c2ccccn2)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
RAB9A P51151 3/20 0.50
KMO O15229 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50
NPC1 O15118 3/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NISCH Q9Y2I1 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
CCR1 P32246 1/20 0.45
CCR5 P51681 1/20 0.45
CCR8 P51685 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45
HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30117410 0.86 RAB9A (0.56) KDM4ERAB9AALDH1A1MAPK1NPC1
SCHEMBL7662434 0.83 KDM4E (0.56) KDM4ERAB9AALDH1A1MAPK1NPC1
SCHEMBL160064 0.83 KDM4E (0.67) KDM4ERAB9AKMOALDH1A1MAPK1
SCHEMBL21022955 0.80 NPC1 (0.49) KDM4ERAB9ANPC1CYP1A2CYP2D6
SCHEMBL2560523 0.79 NISCH (0.49) KMONISCHPIK3CDPI4KAPIK3CG
SCHEMBL13541774 0.79 NPC1 (0.45) KDM4ERAB9AALDH1A1MAPK1NPC1
SCHEMBL20469169 0.79 KDM4E (0.50) KDM4ERAB9AALDH1A1MAPK1NPC1
SCHEMBL30610285 0.79 NPC1 (0.47) KDM4ERAB9ANPC1CYP1A2CYP2D6
SCHEMBL23525622 0.79 NPC1 (0.47) KDM4ERAB9ANPC1CYP1A2CYP2D6
SCHEMBL29739308 0.79 KDM4E (0.50) KDM4ERAB9AALDH1A1MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3577110-B1 8-OXETAN-3-YL-3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL SUBSTITUTED COMPOUNDS AS HIV INHIBITORS GILEAD SCIENCES INC (US) 2021-04-21 EP disclosed